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Abstract—Objective: Lung cancer is the leading cause
of cancer-related death worldwide. Computer-aided diagnosis
(CAD) systems have shown significant promise in recent years
for facilitating the effective detection and classification of abnor-
mal lung nodules in computed tomography (CT) scans. While
hand-engineered radiomic features have been traditionally used
for lung cancer prediction, there have been significant recent
successes achieving state-of-the-art results in the area of discov-
ery radiomics. Here, radiomic sequencers comprising of highly
discriminative radiomic features are discovered directly from
archival medical data. However, the interpretation of predictions
made using such radiomic sequencers remains a challenge.
Method: A novel end-to-end interpretable discovery radiomics-
driven lung cancer prediction pipeline has been designed, build,
and tested. The radiomic sequencer being discovered possesses a
deep architecture comprised of stacked interpretable sequencing
cells (SISC). Results: The SISC architecture is shown to out-
perform previous approaches while providing more insight in
to its decision making process. Conclusion: The SISC radiomic
sequencer is able to achieve state-of-the-art results in lung cancer
prediction, and also offers prediction interpretability in the form
of critical response maps. Significance: The critical response maps
are useful for not only validating the predictions of the proposed
SISC radiomic sequencer, but also provide improved radiologist-
machine collaboration for effective diagnosis.
Index Terms—lung, interpretable, nodule, radiomics, cancer,
discovery radiomics
I. INTRODUCTION
Lung cancer is the most diagnosed form of cancer and the
leading cause of cancer-related death worldwide [1]. Approx-
imately 225,000 new cases in the United States appear each
year and it leads to $12 billion in annual health care costs [2].
In fact, the number of individuals suffering from lung cancer
is greater than all individuals suffering from breast, colon, and
prostate cancer combined.
Early detection and diagnosis of lung cancer is critical as
it can significantly reduce mortality rates. In particular, low
dose computed tomography (CT) imaging has proven to be
one of the most effective ways of detecting early stages of
lung cancer [3]. However, one of the key challenges with lung
cancer detection and diagnosis using CT imaging is that the
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manual screening of CT scans is a very laborious and time-
consuming process. This is true even for expert radiologists,
given the large amount of imaging data that needs to be
analyzed. As such, there is a growing need for computer-
aided diagnosis (CAD) systems which can assist radiologists
in cancer detection in a fast yet accurate manner. Such
systems can provide automatic identification of the cancerous
nodules in CT scans along with useful information about their
malignancy characteristics.
Until recently, state-of-the-art CAD systems relied on
radiomics-based approaches built from hand-engineered ra-
diomic features. These features are designed to character-
ize cancer phenotypes in a high-dimensional feature space
that facilitates tumor discrimination. The extracted radiomic
sequence consists of a large number of predefined, hand-
engineered features for capturing image-based traits such as
intensity, texture, and shape. These hand-engineered features
can greatly limit the ability of the radiomic sequence to fully
characterize the unique traits of different forms of cancer.
More recently, the concept of discovery radiomics [4]–[8]
was shown to achieve state-of-the-art performance. In dis-
covery radiomics, the radiomic sequencers generate highly-
discriminative quantitative radiomic features which are discov-
ered, rather than hand-engineered, from vast amounts of avail-
able archival medical data. In particular, radiomic sequencers
with deep convolutional architectures that are discovered in an
end-to-end manner were shown to consistently achieve state-
of-the art performance in medical imaging analysis. The use
of such radiomic sequencers within the discovery radiomics
framework is particularly effective for lung cancer prediction
using CT imaging. This is due to the availability of very
large annotated CT scan data sets such as LIDC-IDRI [9],
which enables highly discriminative radiomic features to be
discovered directly from this wealth of data.
Despite the effectiveness of discovery radiomics-based ap-
proaches from a diagnostic performance perspective, a key
challenge that still remains is the difficulty in interpreting
the rationale behind their predictions. As such, one can view
such radiomics-based approaches as ’black box’, and the lack
of transparency in their decision-making processes makes it
difficult for radiologists to verify, validate, and ultimately trust
the predictions being made. To enable the widespread adoption
of discovery radiomics within CAD systems, one needs to im-
prove radiologists’ trust by providing interpretable reasoning
behind the predictions made by radiomic sequencers.
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Fig. 1: Overview of the proposed deep stacked interpretable sequencing cell (SISC) architecture used as the radiomic sequencer
within a discovery radiomics framework. The SISC radiomic sequencer is formed by stacking interpretable sequencing cells
together, each comprised of different specialized convolutional layers along with max-pooling and dropout operations. A typical
interpretable sequencing cell consists of a block of convolutional layers followed by batchnorm, dropout, and ReLU layers,
repeated three times. The final interpretable sequencing cell is flexible and can be changed based on the input and task. Here,
the final layer in the last cell consists of two 1×1 convolutions as this study is focused on binary lung cancer classification.
Motivated by this, we propose an end-to-end interpretable
discovery radiomics-driven lung cancer prediction pipeline.
Specifically, the main contributions of our approach are:
• the introduction of SISC architecture (Fig. 1), comprising
of interpretable sequencing cells, for building radiomic
sequencers with state-of-the-art performance for lung
cancer prediction, and
• interpretable lung cancer predictions in the form of crit-
ical response maps generated through a stack of inter-
pretable sequencing cells which highlight the key critical
regions leveraged in the prediction process (Fig. 2).
II. BACKGROUND
There has been significant interest and a wealth of literature
in the past decade, especially in lung cancer detection and
diagnosis [10]–[15]. CAD systems designed for automated
lung cancer diagnosis can be divided into two main stages: 1)
Lung nodule detection and segmentation; and 2) malignancy
classification of segmented nodules.
The first stage consists of processing CT images to isolate
the lung region [16] and search for potential pulmonary nodule
candidates [17], [18]. The process involves finding the location
of the pulmonary nodules in a given CT scan slice by defining
its position and contour [19]. The candidate detection step is
usually followed by false positive reduction algorithms [20]–
[22] to control the rate of candidate generation.
The second stage is the nodule classification process, where
the detected nodules are classified as either malignant or
benign. In particular, there has been significant interest in the
concept of radiomics, which involves the high-throughput ex-
traction and analysis of a large amount of quantitative features
from medical imaging data to characterize tumor phenotypes
in a quantitative manner. Different radiomic feature extraction
techniques and algorithms have been proposed in the literature
to perform the classification task, and can be split into two
broad categories: 1) hand-engineered radiomic features, and
2) learned/discovered radiomic features.
A. Hand-Engineered Radiomic Features
Traditional radiomics-based approaches leveraged pre-
defined, hand-engineered features designed with the help of ra-
diologists [23]–[25]. Such hand-engineered features typically
capture generic image-based traits such as intensity, texture,
and shape. For example, Way et al. [26] used the segmented
nodules to extract texture features and classified them using
linear discriminant classifier. El-Baz et al. [27] used the shape
of nodules as features whereas, Han et al. [28] used 3D
texture analysis to extract discriminative features for nodule
classification. Dhara et al. [29] used an ensemble of margin-
based, shape-based and texture-based features extracted from
the segmented nodule to form the feature set. Support vector
machines were then used to classify the nodule as malignant
or benign using this radiomic feature set.
Aydin et al. [23] used radiologist-provided evaluations to
develop a weighted rule-based algorithm using an ensemble of
classifiers to predict malignancy score. Recently, Robherson et
IEEE TRANSACTIONS OF BIOMEDICAL ENGINEERING 3
al. [11] used taxonomic diversity index and mean plylogenetic
distance to calculate the malignancy score. In general, the most
commonly used feature extraction methods are histogram of
oriented gradients (HOG) [30], [31] and local binary patterns
(LBP) [32]. Different machine learning classifiers such as
support vector machines (SVM) [33], random forests [34] and
weighted nearest neighbour (NN) [35] were used with the
hand-crafted features for classification. One limitation to hand-
engineered radiomic features is that they are typically designed
based on generic image-based features that are not customized
for the task of lung cancer detection and diagnosis, and thus
can greatly limit the classifier’s ability to fully characterize the
unique traits of different forms of cancer.
B. Learned/Discovered Radiomic Features
With the recent advances and success in machine learning,
particularly deep learning [36], many researchers have started
to leverage such approaches for medical image analysis [4],
[37]–[40]. This has led to significant interest in the concept
of discovery radiomics, where high-dimensional quantitative
radiomic features are learned and discovered directly from the
wealth of medical imaging data available. Such discovered
radiomic sequences enable a much more customized character-
ization of tumor phenotype. As one of the first deep learning-
driven discovery radiomics approaches for the purpose of lung
cancer classification, Kumar et al. [41] learned deep radiomic
features using an auto-encoder radiomic sequencer for the
purpose of classifying lung nodules as malignant or benign.
Currently, deep convolutional radiomic sequencers have shown
tremendous success for the task of nodule classification. With
sufficient architectural depth, these radiomic sequencers enable
a robust classification framework that can accommodate the
variability found in characteristics of the lung nodules. For
example, Mario et al. [24] combined shape and appearance
radiomic features with learnt radiomic features from a deep
convolutional radiomic sequencer to form a combined ra-
diomic sequence that is then used to feed a random forest
classifier. Shen et al. [42] proposed a multi-scale convolutional
radiomic sequencer to obtain radiomic features for the purpose
of nodule classification. Zhao et al. [37] proposed a hybrid
radiomic sequencer to combine deep convolutional features
with LBP and HOG features. A novel multi–scale, multi–
view radiomic sequencer architecture was proposed by Liu
et al. [14] for nodule classification. The 3D nature of the CT
scans has also inspired the use of 3D convolutional radiomic
sequencer architectures. Liu et al. [43] proposed a novel 3D
convolutional architecture for lung nodule classification. Zhu
et al. [44] proposed an end–to–end automated lung cancer
detection framework called DeepLung, where 3D dual path
net feature extraction was introduced. Dey et al. [45] proposed
a two-pathway 3D convolutional architecture to capture both
local and global characteristics.
C. Interpretability
While highly complex deep convolutional radiomic se-
quencer architectures can achieve state-of-the-art performance,
one of the biggest limitations to leveraging such sequencers
is that they are very difficult to interpret. As such, researchers
have in recent years explored different approaches for better
understanding the inner workings of such architectures. The
current approaches can be grouped into two categories. The
first group of approaches attempts to understand the global
decision making process of the deep convolutional architec-
tures by identifying inputs which maximize the outputs in
the architecture [46]–[49]. The second group of approaches
provides an explanation for the prediction being made by
generating attentive maps for the input image. The attentive
maps highlight the attentive regions used by the architecture
for making a particular prediction. Since it is important
for clinicians interacting with a CAD system to be able to
visualize critical regions linked to cancer and for the purpose
of justifying the computer-aided lung cancer prediction, we
will discuss the second group of approaches in detail below.
Simonyan et al. [50] used derivatives of the class score
found by back-propagation for each pixel to create the
class saliency map. Zeiler et al. [51] and Springenberg et
al. [52] used a deconvolution-based method and gradient-based
method, respectively, to project activations back to the input
space. A limitation of both methods is that there is no class
information to their visualizations. Zhou et al. [53] proposed to
use global average pooling layers in CNN to create what they
refer to as Class Activation Maps (CAM). Zintgraf et al. [54]
proposed to use multi-variate conditional sampling to visualize
the predictions made by deep convolutional architectures and
highlight the input image’s pixel which contributes for and
against a particular class. Kumar et al. [55] proposed the
concept of CLEAR (CLass-Enhanced Attentive Response)
maps which can provide the per-class attentive interest levels
on each input image’s pixel in the given deep convolutional
architecture.
III. METHODOLOGY
This section describes the design and implementation of
a radiomics sequencer. The modular design of the SISC
architecture (see Section III-B) enables a significant reduction
in the design search space while improving classification
performance. Furthermore, the introduction of interpretable
sequencing cells allow us to achieve end-to-end interpretability
through the generation of critical region maps to aid the
clinician in the decision-making process (see Section III-C).
The LIDC-IDRI dataset (see Section III-A) is used to validate
the proposed radiomic sequencer architecture.
A. Dataset
The Lung Image Database Consortium (LIDC) and Image
Database Resource Initiative (IDRI) [9] published a structured
and categorized repository of computed tomography (CT)
scans to assist the development of CAD methods for automated
lung cancer diagnosis. The dataset consists of 1018 thoracic
CT scans, where each scan is processed by four radiologists at
both blinded and un–blinded stages. In the blinded stage, each
radiologist reviews the CT scans without inputs from other
radiologists. In the second, un–blinded stage, each radiologist
is shown the results of other radiologists from the blinded stage
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Fig. 2: Overview of the end-to-end interpretable discovery radiomics-driven framework for lung cancer prediction. Part (a)
shows the sequencer discovery process, where a specialized radiomic sequencer, comprised of a deep stack of interpretable
sequencer cells, is discovered for the given set of CT lung nodule data. Part (b) presents the cancer prediction process, where
the discovered radiomic sequencer is used to make a prediction based on CT data and how interpretable critical response maps
are generated through the stack of sequencer cells. In part (b), the input CT data of a new patient is fed into the radiomic
sequencer to generate a radiomic sequence and perform prediction on whether it is a benign and malignant case. To generate
the critical response map, the output of the last layer in the sequencing cell of the radiomic sequencer is backpropagated
through each sequencing cell using the method described in Section III-C for each of the possible prediction states (benign and
malignant). As such, we obtained two critical response maps, each highlighting the critical regions used by the sequencer for
making predictions regarding whether the given input nodule is benign or malignant. The last part (c) is the interface seen by
the end user, which shows the given input, the prediction and evidence been used to obtain the particular prediction through
critical response map.
and is given a chance to change their initial evaluations. The
two stage process was designed to provide the best estimate
of the nodule characteristics.
The suspected lung lesions in the LIDC dataset are divided
into three categories: i) Non-nodule≥3mm, ii) Nodule≥3mm,
and iii) Nodule<3mm, where the diameter is measured as the
length of the lesion’s longest axis. For each category, different
nodule characteristics are included in the dataset. Similar to
previous methods, we decided to only use Nodule≥3mm.
For the Nodule≥3mm category, the required malignancy
score along with the nodule location and contour infor-
mation by at least one radiologist are included. Therefore,
the Nodule≥3mm category is used for our experiments. A
total of 2669 nodules are reported in the dataset under the
Nodule≥3mm category.
For each nodule, its characteristics are provided by at most
four radiologists. The final malignancy score for each nodule is
obtained by combining the scores from all of the radiologists.
As suggested in [28], the average score rounded to the nearest
integer was taken as the final malignancy score. In each slice
of the given nodule, a 96 × 96 window was cropped at the
nodule center. The size was determined to accommodate for
all the variability in the nodule contour and also to include
sufficient background information. The same malignancy score
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Fig. 3: Data preparation flow for i) computing malignancy score, and ii) obtaining an 96×96 nodule image directly from the
raw LIDC-IDRI dataset. For a given lung CT slice image (a), the LIDC-IDRI dataset contains lung nodule masks from up
to four radiologist (b). We use these masks to locate the contour of the nodule in the CT slice image. As can be seen in the
zoomed-in images in (c), the contours of the mask differ due to the inter-observer variability. To mitigate this, we selected an
sub-image of 96×96 from the average center pixel obtained from the radiologist masks to create a single 96×96 lung nodule
image (d). For computing the malignancy score (as shown in (d)), we average the scores given by the radiologists as indicated
in part (c). A detailed discussion on data preparation is discussed in Section III part A.
was assigned for all the slices in the given nodule. A total
of 14, 433 nodule images along with their corresponding
malignancy score were extracted from the dataset.
B. Interpretable Sequencing Cells
A modular design strategy was leveraged to construct the
proposed SISC radiomics sequencer, where the underlying
architecture is comprised of a deep stack of interpretable
sequencing cells with similar micro-architectures. More specif-
ically, an intepretable sequencing cell as introduced in this
study comprises of a block of convolutional layers along
with max-pooling and dropout operations, all optimized using
the available data. The proposed SISC radiomic sequencer is
then constructed by stacking the interpretable sequencing cells
together in a depth-wise manner. The aim is to reduce the
design search space while improving classification accuracy,
thus enabling optimized design of sequencer architectures
in a more predictable manner. The micro-architecture of an
interpretable sequencing cell is defined by three convolu-
tional layers separated by batch normalization [56] and drop–
out [57]. Furthermore, the ReLU [58] activation is used
after each convolutional layer. The interpretable sequencing
cell is optimized by sharing the same architectural values.
For example, all the dropout layers in a given interpretable
sequencing cell have the same dropout rate.
In this study, the proposed SISC radiomic sequencer is
comprised of four interpretable sequencing cells stacked to-
gether in a depth-wise manner as shown in Fig 1. The number
of channels is increased as we go deeper into the SISC
architecture whereas the size of the kernel is fixed for the
first three cells. Each cell is followed by a max pooling layer.
The dropout, batch normalization parameters and number of
cells are optimized with the LIDC-IDRC dataset. The final cell
of the SISC radiomic sequencer is defined as shown in Fig. 1.
The number of kernels in the final convolutional layer of the
final cell is equivalent to the total number of classes to enable
end-to-end interpretability via critical response maps, which
will be further discussed in the following section. The final
convolutional layer is followed by a global average pooling
layer, which is then followed by a softmax output layer.
The proposed SISC radiomic sequencer formed by the
stacking of interpretable sequencing cells with learned param-
eters is shown in Fig 1. We can observe that the repeated mod-
ular approach allows us to compactly define the sequencer with
a minimum number of configurable architectural parameters.
The modular approach also leads to state-of-the-art results as
described in Section IV.
C. Interpretability through Critical Response Maps
To enable interpretability and explainability in the decision-
making process of the proposed SISC radiomic sequencer, we
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Fig. 4: Example critical response maps for malignant cases. (a) original 96×96 malignant nodule sub-image taken from lung CT
slices with the radiologist-provided best contours for a given patient CT slice image, and (b) corresponding critical response
maps showing the malignant critical regions been used for correctly predicting malignant nodules. It can be seen that for
almost all the example cases, the proposed SISC radiomic sequencer uses clinically relevant markers when achieving correct
predictions. Therefore, the use of critical response maps can potentially improve the overall confidence of the clinician on the
discovered SISC radiomic sequencer.
Fig. 5: Example critical response maps for benign cases. (a) original 96×96 malignant nodule sub-image taken from lung CT
slices with the radiologist-provided best contours for a given patient CT slice image, and (b) corresponding critical response
maps showing the benign critical regions been used for correctly predicting benign nodules. It can be seen that for almost all
the example cases, the proposed SISC radiomic sequencer uses clinically relevant markers when achieving correct predictions.
Therefore, as with the previous figure, the use of critical response maps can potentially improve the overall confidence of the
clinician on the discovered SISC radiomic sequencer.
take inspiration from [55] and [59] and introduce an approach
where critical response maps are generated through the entire
stack of interpretable sequencing cells. An critical response
map provides spatial insights on critical regions in the CT
scan and their level of contribution to a particular prediction
made. Here, an individual critical response map is generated
for each possible prediction (benign and malignant).
Using these critical response maps, the clinician can not
only validate the the evidence behind the predictions made
using the proposed SISC radiomic sequencer, but the maps
also help in locating relevant regions in the CT scan respon-
sible for either a malignant or benign nodule prediction. An
example pair of critical response maps can be seen in Fig. 2.
For example, in the case of a malignant nodule, a successful
and reasonable prediction should lead to the malignant critical
map highlighting the nodule regions. As such, critical response
maps may potentially help radiologists to have greater confi-
dence in the CAD system and in aiding them with their clinical
diagnosis decisions.
The critical response map generation process can be de-
scribed as follows. Let the critical response maps A(x|c)
for a given CT scan slice image x for each prediction c be
computed via back-propagation from the last layer of the last
interpretable sequencing cell in the proposed SISC radiomic
sequencer. The notation used in this study are based on the
study done by Kumar et. al. [55] for consistency. As shown
in Fig 1, the last layer in the interpretable sequencing cell
at the end of the proposed SISC radiomic sequencer contains
N = 2 nodes, equal to the number of possible predictions (i.e.,
benign and malignant). The output activations of this layer
are followed by global average pooling and then a softmax
output layer. So, to create the critical maps for each possible
prediction, the back-propagation starts with the individual
prediction nodes in the last layer to the input space. For a
single layer l, The deconvolved output response rˆl is given
by,
hˆl =
K∑
k=1
fk,l ∗ pk,l (1)
where fk is the feature map and pl is the kernel of layer l. the
symbol ∗ represents the convolution operator. For simplicity,
The convolution and summation can be combined as hˆl =
Dlfl. Therefore, the critical response map A(x|c), for a given
prediction c is defined as,
A(x|c) = D1M ′1D2M ′2....DL−1M ′L−1DcLFL. (2)
Where M ′ is the un-pooling operation as described in [60] and
DcL is the convolution operation at the last layer with kernel
pL replaced by zero except at the cth location corresponding
to the prediction c.
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TABLE I: Number of samples for corresponding malignancy
scores, for three different datasets. The datasets were created
based on how the radiologist malignancy rating 3 was treated
i.e., Ignored (I), treated as benign (B), or treated as malignant
(M).
Malignancy
score Size I B M
1 1376
3981
9638
3981
2 2605
3 5657 Ignored
104524 3192
4795 4795
5 1603
IV. EXPERIMENTS AND RESULTS
In this section, we will evaluate and discuss the efficacy
for the proposed SICS radiomic sequencer for the purpose of
lung cancer prediction on two main fronts: i) cancer prediction
performance of the proposed sequencer compared to state-
of-the-art, and ii) interpretability of the cancer predictions
made by the proposed sequencer through the generated critical
response maps.
A. Experimental Setup
The setup of the experiments in this study can be described
as follows. The cropped lung nodule images with their cor-
responding malignancy scores are obtained from the LIDC-
IDRI dataset as explained in section III-A. The distribution of
the malignancy scores in the dataset is described in Table I.
Malignancy scores 1 and 2 are considered as benign, whereas
scores 4 and 5 are considered as Malignant. The malignancy
score 3 can be either considered as benign, malignant or
ignored depending as done by previous studies in this field. In
this paper, we have created three different datasets where the
score 3 is considered malignant (dataset: ‘M’), benign (dataset:
‘B’), and ignored (Dataset: ‘I’). The final dataset distribution
is shown in Table I. Each dataset was further divided into
80% training data, 10% for validation and 10% testing data.
The pre-processing and dataset distribution is similar to Xie
et. al. [10].
Table II shows the distribution of training data for the three
datasets. We can observe that dataset ‘B’ and ‘M’ are not
evenly distributed. To mitigate this imbalance, data augmen-
tation was performed on each of the datasets to balance the
number of examples associated with each class. Furthermore,
the data augmentation performed also acts to enhance the
variability and generalizability of the radiomic sequencer.
In particular, random horizontal shifts, vertical shifts, and
rotations were applied along with vertical and horizontal flips
to construct the augmented training dataset. Since the size of
the training data has a huge impact on the performance of
the proposed radiomic sequencer, three different augmented
datasets with varying size were created for each of the ‘M’,
‘B’ and ‘I’ datasets, as shown in Table II. The performance
of dataset ’I’ under different levels of data augmentation is
shown in Fig 10. We can observe that the ≈ 15k size yielded
the best performance. Going forward, we have finalized the
dataset size to be ≈ 15k for further hyper-parameter tuning
and validations for the ‘M’, ‘B’ and ‘I’ datasets.
Different data normalization techniques such as standard
deviation, Min-Max, and ZCA whitening [61] were also ap-
plied to the lung nodule images. It was found that Min-Max
normalization yielded the best results. After optimizing the
hyper-parameter using the validation set, batch normalization
was implemented with momentum= 0.99 and dropout layer
was used with rate= 0.25. The Adam optimizer was used with
learning rate = 1e−5 and batch size as 128. The proposed
radiomic sequencer was learnt for approximately 200 epochs
and evaluated against the test dataset. The final results were
reported by averaging over 10-fold cross validation for all three
datasets.
B. Cancer prediction performance
To evaluate the cancer prediction performance of the pro-
posed SISC radiomic sequencer, we computed the sensitivity,
specificity, accuracy, and AUC of the proposed sequencer and
compared it with five other state-of-the-art approaches. The
average lung cancer prediction performance of the proposed
radiomic sequencer for dataset ‘M’, ‘B’ and ‘I’ are shown in
Table. V & IV & III respectively. The AUC curves of the
10 different cross validation runs for each dataset are shown
in Figs. 6, 7 & 8. The best performing AUC curve from
each dataset is shown in Fig. 9. From the results, we can
observe that, for the dataset ‘I’, by leveraging the proposed
SISC radiomic sequencer, we were able to achieve comparable
performance with the current state-of-the-art method proposed
by Xie et al. [10]. For datasets ‘B’ and ‘M’, the proposed
sequencer is able to outperform the accuracy results from Xie
et al. [10]. The comparison of the existing and current state-of-
the-art methods with the proposed SISC radiomic sequencer
is given in Table. V & IV & III. The comparison methods
are based on the previous studies in this field, employing the
same data pre–processing steps for fair comparison amongst
the methods. Based on these experimental results, it can be
observed that the proposed SISC radiomic sequencer can
provide strong cancer prediction performance that exceeds
state-of-the-art in all but one case, where in that case the
performance is comparable to state-of-the-art.
C. Interpretability
Here, we will investigate the efficacy of the proposed
SISC radiomic sequencer in terms of interpretability of the
lung cancer predictions made. Fig. 4 shows example critical
response maps generated in an end-to-end manner for sev-
eral example malignant nodule images that were correctly
predicted to be malignant. From the figure, it can be ob-
served that the proposed SISC radiomic sequencer is able
to successfully identify the nodule regions in the given CT
slices without being explicitly directed to do so. As shown
in Fig. 4, the highlighted region’s contour closely matches
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TABLE II: Dataset distribution for the three different dataset
configuration obtained from the LIDC-IDRI dataset before and
after data augmentation (as described in Section IV-A).
Dataset Grade BeforeData Aug 15k 30k 60k
I
Malignant 3836 9836 15836 30836
Benign 3184 9184 15184 30184
Total 7020 19020 31020 61020
B
Malignant 3836 7672 19180 38360
Benign 7712 7712 21712 35712
Total 11548 15384 40892 74072
M
Malignant 8361 8361 16361 33444
Benign 3187 6374 15935 28683
Total 11548 14735 32296 62127
TABLE III: Performance comparison between tested cancer
prediction methods for the ignored (I) dataset. Best results are
highlighted in bold.
Method Accuracy Sensitivity Specificity AUC
Han et al. [28] 85.59 70.62 93.02 89.25
Dhara et al. [29] 88.38 84.58 90.03 95.76
Shen et al. [38] 87.14 77.00 93.00 93.00
Sun et al. [62] - - - 88.23±1.70
Xie et al. [10] 89.53±0.09 84.19±0.09 92.02±0.01 96.65±0.01
Ours (SISC) 89.36±1.20 90.28±2.00 88.25±2.00 96.01±0.70
TABLE IV: Performance comparison between tested cancer
prediction methods for the benign (B) dataset. Best results are
highlighted in bold.
Method Accuracy Sensitivity Specificity AUC
Han et al. [28] 87.36 73.75 93.37 93.79
Dhara et al. [29] 87.69 80.00 89.30 94.44
Xie et al. [10] 87.74±0.03 81.11±0.85 89.67±0.09 94.45±0.01
Ours (SISC) 88.57±1.70 78.32±8.12 93.66±2.06 94.34±0.08
the contours given by the radiologists, and in some cases
provide improved contour localization than that provided by
the radiologists. The proposed SISC radiomic sequencer is able
to successfully highlight a wide range of nodules with different
shapes and sizes. We can also infer the discriminative nature
of the proposed sequencer by observing that the highlighted
regions in the critical response maps that contribute highly
to a malignancy prediction. This helps to gain better insight
in the rationale behind the malignancy prediction. Similar
observations can also be observed for benign nodules as shown
TABLE V: Performance comparison between tested cancer
prediction methods for the malignant (M) dataset. Best results
are highlighted in bold.
Method Accuracy Sensitivity Specificity AUC
Kumar et al. [41] 75.01 83.35 - -
Han et al. [28] 70.97 53.61 89.41 76.26
Dhara et al. [29] 71.17 53.47 89.74 79.74
Sharma et al. [63] 84.13 91.69 73.16 -
Xie et al. [10] 71.93±0.04 59.22±0.04 84.85±0.10 81.24±0.01
Ours (SISC) 84.17±1.50 90.71±4.01 67.00±8.64 89.06±1.20
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Fig. 6: Receiver operating curve (ROC) for the ignored (I)
dataset for 10 different cross validation runs.
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Fig. 7: Receiver operating curve (ROC) for the benign (B)
dataset for 10 different cross validation runs.
in Fig.5.
Due to the end-to-end interpretable nature of the proposed
SISC radiomic sequencer, the critical response maps produced
through the entire stack of interpretable sequencing cells can
potentially help improve the confidence of radiologists work-
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Fig. 9: Comparing the best ROC curves for the three different
datasets: ignored (I), benign (B) and malignant (M).
ing with the CAD system. Furthermore, the critical response
maps can also assist radiologists to more consistently and
rapidly spot abnormal nodules within the large volume of a
CT scan, as well as understand the nature and characteristics
most linked to malignancy.
V. CONCLUSION
In this paper, we introduce a novel end-to-end interpretable
discovery radiomics-driven lung cancer prediction framework.
This framework is enabled by the proposed radiomic se-
quencer: a deep stacked interpretable sequencing cell (SISC)
architecture comprised of interpretable sequencing cells. Ex-
perimental results show that the proposed SISC radiomic
sequencer is able to not only achieve state-of-the-art results in
lung cancer prediction, but also offers prediction interpretabil-
ity in the form of critical response maps generated through the
stack of interpretable sequencing cells which highlights the
critical regions used by the sequencer for making predictions.
The critical response maps are useful for not only validating
the predictions of the proposed SISC radiomic sequencer, but
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Fig. 10: Accuracy, sensitivity, and specificity for the “ignored”
(I) dataset for three different training sample sizes. It can be
observed that the ≈15k size performed the best for 3 out of
4 metrics, including AUC; hence it was chosen as the default
training size for the three different dataset categories: ignored
(I), benign (B), and malignant (M).
also provide improved radiologist-machine collaboration for
improved diagnosis.
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